Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.63% | 13.43% | |||
| Total Other Revenue | -97.85% | -- | |||
| Total Revenue | -8.80% | 17.47% | |||
| Cost of Revenue | -5.47% | 16.52% | |||
| Gross Profit | -10.42% | 17.93% | |||
| SG&A Expenses | -18.18% | 1.45% | |||
| Depreciation & Amortization | 0.09% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.77% | 7.13% | |||
| Operating Income | 71.03% | 46.84% | |||
| Income Before Tax | 46.13% | 38.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.13% | 39.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.13% | 39.01% | |||
| EBIT | 71.03% | 46.84% | |||
| EBITDA | 233.76% | 74.34% | |||
| EPS Basic | 50.43% | 43.07% | |||
| Normalized Basic EPS | 50.34% | 42.17% | |||
| EPS Diluted | 50.43% | 43.07% | |||
| Normalized Diluted EPS | 50.34% | 42.17% | |||
| Average Basic Shares Outstanding | 8.60% | 7.16% | |||
| Average Diluted Shares Outstanding | 8.60% | 7.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||